Use of insertional inactivation to facilitate studies of biological properties of pneumococcal surface protein A (PspA).
about
Choline Binding Proteins from Streptococcus pneumoniae: A Dual Role as Enzybiotics and Targets for the Design of New AntimicrobialsThe human milk protein-lipid complex HAMLET sensitizes bacterial pathogens to traditional antimicrobial agentsPspA, a surface protein of Streptococcus pneumoniae, is capable of eliciting protection against pneumococci of more than one capsular typeHelper T cell epitope-mapping reveals MHC-peptide binding affinities that correlate with T helper cell responses to pneumococcal surface protein A.Surface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelope.Capsule biosynthesis and basic metabolism in Streptococcus pneumoniae are linked through the cellular phosphoglucomutase.Deletion of repeats in the alpha C protein enhances the pathogenicity of group B streptococci in immune mice.Mapping of epitopes recognized by antibodies induced by immunization of mice with PspA and PspC.Pneumococcal diversity: considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA).The autolytic enzyme LytA of Streptococcus pneumoniae is not responsible for releasing pneumolysinPneumococcal surface protein A inhibits complement activation by Streptococcus pneumoniae.The pspC gene of Streptococcus pneumoniae encodes a polymorphic protein, PspC, which elicits cross-reactive antibodies to PspA and provides immunity to pneumococcal bacteremiaAdditive attenuation of virulence of Streptococcus pneumoniae by mutation of the genes encoding pneumolysin and other putative pneumococcal virulence proteins.Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae.Immunization of mice with combinations of pneumococcal virulence proteins elicits enhanced protection against challenge with Streptococcus pneumoniae.Genetic immunization with the region encoding the alpha-helical domain of PspA elicits protective immunity against Streptococcus pneumoniaeProtection against Streptococcus pneumoniae elicited by immunization with pneumolysin and CbpA.Pneumococcal virulence factors: structure and functionTHP-1 monocytes up-regulate intercellular adhesion molecule 1 in response to pneumolysin from Streptococcus pneumoniae.Role of pneumococcal surface protein C in nasopharyngeal carriage and pneumonia and its ability to elicit protection against carriage of Streptococcus pneumoniaeMn2+-dependent regulation of multiple genes in Streptococcus pneumoniae through PsaR and the resultant impact on virulence.Genetic alteration of capsule type but not PspA type affects accessibility of surface-bound complement and surface antigens of Streptococcus pneumoniae.Immunization with Salmonella enterica serovar Typhimurium-derived outer membrane vesicles delivering the pneumococcal protein PspA confers protection against challenge with Streptococcus pneumoniae.Both family 1 and family 2 PspA proteins can inhibit complement deposition and confer virulence to a capsular serotype 3 strain of Streptococcus pneumoniaeContribution of different pneumococcal virulence factors to experimental meningitis in mice.Antipneumococcal effects of C-reactive protein and monoclonal antibodies to pneumococcal cell wall and capsular antigens.Contribution of autolysin to virulence of Streptococcus pneumoniae.Pneumococcal surface protein A (PspA) is serologically highly variable and is expressed by all clinically important capsular serotypes of Streptococcus pneumoniae.Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae.Differential role of CbpA and PspA in modulation of in vitro CXC chemokine responses of respiratory epithelial cells to infection with Streptococcus pneumoniae.A pneumolysin-negative mutant of Streptococcus pneumoniae causes chronic bacteremia rather than acute sepsis in mice.Sequence heterogeneity of PsaA, a 37-kilodalton putative adhesin essential for virulence of Streptococcus pneumoniaeCharacterization of hemin binding activity of Streptococcus pneumoniae.Oral immunization with PspA elicits protective humoral immunity against Streptococcus pneumoniae infection.Cloning and characterization of nanB, a second Streptococcus pneumoniae neuraminidase gene, and purification of the NanB enzyme from recombinant Escherichia coli.CCL5-independent helper T lymphocyte responses to immuno-dominant pneumococcal surface protein A epitopesFunctional activity of antibodies to the group B polysaccharide of group B streptococci elicited by a polysaccharide-protein conjugate vaccine.Pneumolysin, PspA, and PspC contribute to pneumococcal evasion of early innate immune responses during bacteremia in mice.Contributions of pneumolysin, pneumococcal surface protein A (PspA), and PspC to pathogenicity of Streptococcus pneumoniae D39 in a mouse model.Nontypeable pneumococci can be divided into multiple cps types, including one type expressing the novel gene pspK
P2860
Q26744448-6133AEB5-D3F6-488F-8373-444554E36F0AQ28482276-446B14CB-765D-409C-BFC4-4AC076FD2016Q33513623-33010864-4EC8-4A20-B3E9-722A2D9527E4Q33535951-4BDFC113-1A55-4B2C-937C-A098A9B678C2Q33538951-A258D65E-F9BF-4DCE-B3B9-AC0B61199F22Q33601553-A6AD69D0-5810-4240-BEB3-71B4B5BE56DDQ33762432-323F945E-4FCE-45C2-93AF-46F16EAE2C26Q33899358-34C8AD25-FD77-4BFF-AC4A-76533C9C9D5EQ33975380-6608147F-177C-49ED-81F6-4B5DE9DCD63DQ33996189-2C1B99F3-601D-4BB7-BD4F-1E310FC9D644Q34001813-1B4B4A93-8B0C-4A4C-9CD2-208795D4BD53Q34002787-8CC06BC2-D758-4ECD-897F-44126D87764AQ34002986-7E6590BD-26B8-4F6E-A508-5ED66DF0F5BEQ34003306-1BD52A82-754B-4EB2-BABB-F7ECA6949F79Q34004489-EA31E871-0695-4F7E-A36E-CFDF0B464D1DQ34008890-9EFA58E6-004D-4572-8435-F755D3E605E9Q34009174-9F9AF010-F177-4D5A-B1A6-D37CAC9FF593Q34010335-1C9DFDDE-6332-4918-A383-925F4FABF8BDQ34033292-1A950C80-12BF-4082-B815-1F46E1429275Q34121334-AADAA4B5-36F1-4FE6-B0FB-FF12B44EE671Q34334220-D426D371-169E-42F2-B086-35183CA8E67FQ34521565-FA0A19D0-E68A-46F6-B14A-CC777E737676Q34529570-81ABD481-F35A-4924-A512-B4ABFFDD8452Q34530684-DA8DC86A-8306-4F06-8201-8973CABF70A3Q34995406-83B3CF54-20F7-47CA-873A-8949B2BBC10FQ35095675-084BAB2A-424B-4EA1-BA11-D1C42B5D3CA8Q35099865-7518C5CE-4F17-4BD3-A9F1-B9A7F4809EF8Q35105898-AD4766D7-0426-48ED-ACF6-2D1E34905CDCQ35111311-7F4CCA9B-8237-4B8D-8187-F780738BFB54Q35220280-B1DC1BAE-ADD4-4278-B630-6AC41F60172FQ35383614-55E0B4EB-95BF-47E9-B8DC-B77112FCB814Q35532255-B158E5CE-5C86-4765-A057-D507EF2A5AABQ35544480-4FA58688-05BF-468E-A926-49FCEE5AC8AFQ35567265-6500B1B2-ED00-4D9E-8E13-DD29D32D54F1Q35610927-0905C404-6EC6-40FF-AB89-1AA9DD66FF0AQ35717991-ED89ECC3-D67D-4B16-9D3C-CB7548B5EE0CQ35778597-23A66ABC-2AE7-40FF-B0EC-EDD9E7E49566Q35783747-BB3AE794-7712-4AB6-9E5A-74F441B4D52FQ35783885-D89F54D4-5A78-4F33-B936-2209D1D4FD8CQ35924482-B74A3C07-102D-4747-AAA9-61DCDB29E08F
P2860
Use of insertional inactivation to facilitate studies of biological properties of pneumococcal surface protein A (PspA).
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh
1987年學術文章
@zh-hant
name
Use of insertional inactivatio ...... ccal surface protein A (PspA).
@ast
Use of insertional inactivatio ...... ccal surface protein A (PspA).
@en
type
label
Use of insertional inactivatio ...... ccal surface protein A (PspA).
@ast
Use of insertional inactivatio ...... ccal surface protein A (PspA).
@en
prefLabel
Use of insertional inactivatio ...... ccal surface protein A (PspA).
@ast
Use of insertional inactivatio ...... ccal surface protein A (PspA).
@en
P2093
P2860
P356
P1476
Use of insertional inactivatio ...... ccal surface protein A (PspA).
@en
P2093
D E Briles
L S McDaniel
M Vijayakumar
P2860
P304
P356
10.1084/JEM.165.2.381
P407
P577
1987-02-01T00:00:00Z